Drug Database
Back to search

United States· US:70771-1787_2bd0ca3f-183d-4af2-8c0e-962115d97fed

Scopolamine

A scopolamine product containing scopolamine, registered in United States by Zydus Lifesciences Limited. The same ATC class is registered in 3 of our 19 countries.

ATC N05CM05US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedScopolamineATCN05CM05REGISTER NO.US:70771-1787_2bd0ca3…PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about scopolamineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Scopolamine is registered in 3 of 19 countries.

Countries holding a registration under ATC N05CM05 (scopolamine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 2 of them publish a price we can compare per daily dose
Search scopolamine products by name

Scopolamine · ATC N05CM05

3 / 19 countries

  • Canada
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SCOPOLAMINE
Manufacturer
Zydus Lifesciences Limited
Country
United States (US)
ATC code
N05CM05
ATC class
Scopolamine
Defined daily dose
0.9 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    7077117872
    10 POUCH in 1 CARTON (70771-1787-2) / 1 PATCH in 1 POUCH / 3 d in 1 PATCH
  • ndc11
    7077117874
    4 POUCH in 1 CARTON (70771-1787-4) / 1 PATCH in 1 POUCH (70771-1787-1) / 3 d in 1 PATCH
  • ndc11
    7077117877
    24 POUCH in 1 CARTON (70771-1787-7) / 1 PATCH in 1 POUCH / 3 d in 1 PATCH
  • ndc11
    70771-1787-2
  • ndc11
    70771-1787-4
  • ndc11
    70771-1787-7

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

335 interactions on record for scopolamine.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check scopolamine against other medicinesHow interaction checks work

Scopolamine · interactions on record

335 records

  • 7 severe
  • 197 moderate
  • 17 minor
  • 114 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DextropropoxypheneN02AC04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Scopolamine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All scopolamine products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Belgium · Scopolamine Hbr Sterop
  • Germany · Boro-Scopol N, Scopoderm Tts
  • Denmark · Scopoderm
  • Spain · Escopolamina B. Braun
  • Finland · Scopoderm
  • France · Bromhydrate De Scopolamine Renaudin, Scopoderm Tts
  • United Kingdom (Northern Ireland) · Hyoscine Hydrobromide Wockhardt Uk, Hyoscine Martindale Pharma
  • Ireland · Hyoscine Injection Bp Ethypharm, Kwells
  • Iceland · Scopoderm
  • Luxembourg · Scopoderm Tts
  • Malta · Kwells
  • Netherlands · Scopoderm
  • Norway · Scopoderm
  • Sweden · Scopoderm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bf911c8e-8bd2-4e2c-afd4-0c8842f3374c
GET /v1/drugs/bf911c8e-8bd2-4e2c-afd4-0c8842f3374c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TRANSDERMAL",
  "source": "ndc",
  "strength": "1",
  "substance": "SCOPOLAMINE",
  "productndc": "70771-1787",
  "dosage_form": "PATCH, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/3d",
  "application_number": "ANDA217893",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about scopolamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console